Log in to save to my catalogue

NeuroRx and Relief Therapeutics submit Emergency Use Authorization for COVID-19 in USA

NeuroRx and Relief Therapeutics submit Emergency Use Authorization for COVID-19 in USA

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss__A636433035

NeuroRx and Relief Therapeutics submit Emergency Use Authorization for COVID-19 in USA

About this item

Full title

NeuroRx and Relief Therapeutics submit Emergency Use Authorization for COVID-19 in USA

Publisher

IMSworld Publications Ltd

Journal title

R and D focus drug news, 2020-09

Language

English

Formats

Publication information

Publisher

IMSworld Publications Ltd

More information

Alternative Titles

Full title

NeuroRx and Relief Therapeutics submit Emergency Use Authorization for COVID-19 in USA

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_incontextgauss__A636433035

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss__A636433035

Other Identifiers

ISSN

1350-1135

E-ISSN

1350-1135

How to access this item